EW vs CSLLY
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
EW · Edwards Lifesciences$102.14 ▲ 1.31%
CSLLY · CSL LTD SPON ADR EACH REPR 0.25 ORD$34.76 ▼ 0.57%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- EW +21.5%
- CSLLY +22.1%
Head to head
| Metric | EW | CSLLY |
|---|---|---|
| Price | $102.14 | $34.76 |
| Change today | ▲ 1.31% | ▼ 0.57% |
| Market cap | $58.73B | $58.62B |
| Return, 3 months | +11.0% | +48.2% |
| Return, year to date | +19.8% | +23.8% |
| Return, 1 year | +22.5% | +22.8% |
| P/E (TTM) | 57.7 | – |
| P/B | 5.4 | 4.5 |
| P/E percentile vs own 5y | 100th | – |
| Dividend yield | – | 2.04% |
| Revenue growth (YoY, latest qtr) | +13.6% | – |
| Net profit growth (YoY) | -27.2% | – |
| Gross margin | 77.8% | – |
| Operating margin | 28.1% | – |
| Net margin | 15.4% | – |
| Return on equity | 9.5% | – |
| Analyst target vs. price | +12.8% | – |
| Analyst buy share | 95% | – |
| RSI (14) | 77 | 63 |
| 30-day volatility | 25.8% | 20.6% |
| Max drawdown, 1 year | -13.2% | -52.2% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- EW is the largest of the group by market value.
- CSLLY has returned the most over the past year.
- CSLLY has been the calmest stock over the last 30 days.